Evidence map›Paper›PMID 40198128›Full record

ArticleJCI insight2025

Mutational landscape of atherosclerotic plaques reveals large clonal cell populations.

Lasse Bach Steffensen, Stephanie Kavan, Pia Søndergaard Jensen, Matilde Kvist Pedersen, Steffen Møller Bøttger, Martin Jakob Larsen, Maja Dembic, Otto Bergman, Ljubica Matic, Ulf Hedin and 6 more

Abstract read
In one paragraph

Article in JCI insight, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Lasse Bach SteffensenDepartment of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
Stephanie KavanCentre for Individualized Medicine in Arterial Diseases (CIMA).
Pia Søndergaard JensenCentre for Individualized Medicine in Arterial Diseases (CIMA).
Matilde Kvist PedersenDepartment of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
Steffen Møller BøttgerDepartment of Clinical Genetics, Odense University Hospital, Odense, Denmark.
Martin Jakob LarsenDepartment of Clinical Genetics, Odense University Hospital, Odense, Denmark.
Maja DembicDepartment of Clinical Genetics, Odense University Hospital, Odense, Denmark.
Otto BergmanDepartment of Molecular Medicine and Surgery, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.
Ljubica MaticDepartment of Molecular Medicine and Surgery, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.
Ulf HedinDepartment of Molecular Medicine and Surgery, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.
Lars van Brakel AndersenDepartment of Clinical Genetics, Odense University Hospital, Odense, Denmark.
Jes Sanddal LindholtCentre for Individualized Medicine in Arterial Diseases (CIMA).
Kim Christian HoulindDepartment of Regional Health Research, Lillebælt Hospital, Kolding, Denmark.
Lars Peter RiberDepartment of Cardiothoracic Surgery, Odense University Hospital, Odense, Denmark.
Mads ThomassenDepartment of Clinical Genetics, Odense University Hospital, Odense, Denmark.
Lars Melholt RasmussenCentre for Individualized Medicine in Arterial Diseases (CIMA).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The notion of clonal cell populations in human atherosclerosis has been suggested but not demonstrated. Somatic mutations are used to define cellular clones in tumors. Here, we characterized the mutational landscape of human carotid plaques through whole-exome sequencing to explore the presence of clonal cell populations. Somatic mutations were identified in 12 of 13 investigated plaques, while no mutations were detected in 11 non-atherosclerotic arteries. Mutated clones often constituted over 10% of the sample cell population, with genes related to the contractile apparatus enriched for mutations. In carriers of clonal hematopoiesis of indeterminate potential (CHIP), hematopoietic clones had infiltrated the plaque tissue and constituted substantial fractions of the plaque cell population alongside locally expanded clones. Our findings establish somatic mutations as a common feature of human atherosclerosis and demonstrate the existence of mutated clones expanding locally, as well as CHIP clones invading from the circulation. While our data do not support plaque monoclonality, we observed a pattern suggesting the coexistence of multiple mutated clones of considerable size spanning different regions of plaques. Mutated clones are likely to be relevant to disease development, and somatic mutations will serve as a convenient tool to uncover novel pathological processes of atherosclerosis in future studies.

Indexed as

AtherosclerosisMutationPlaque, AtheroscleroticAgedCarotid ArteriesClonal HematopoiesisClone CellsExome SequencingFemaleHumansMaleMiddle AgedAtherosclerosisClonal selectionGeneticsGenetic variationVascular biology

Identifiers

PMID40198128
PMCPMC12128991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.